Gavin, James R. and Bailey, Clifford (2021). Real-world studies support use of continuous glucose monitoring in Type 1 and Type 2 diabetes independently of treatment regimen. Diabetes Technology & Therapeutics, 23 (S3), S19-S27.
Gavin, James (2021). Investigation of a Selective Transglutaminase 2 Antagonist as a Novel Therapeutic Agent for Cystic Fibrosis. PHD thesis, Aston University.
